U.S. Markets open in 1 hr 26 mins
S&P Futures
2,446.00
+4.50 (+0.18%)Dow Futures
21,843.00
+48.00 (+0.22%)
| Previous Close | 33.15 |
| Open | 33.07 |
| Bid | 33.18 x 1000 |
| Ask | 33.50 x 600 |
| Day's Range | 33.07 - 33.39 |
| 52 Week Range | 29.83 - 35.19 |
| Volume | 16,119,454 |
| Avg. Volume | 18,231,928 |
| Market Cap | 197.69B |
| Beta | 1.05 |
| PE Ratio (TTM) | 27.98 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 1.28 (3.86%) |
| Ex-Dividend Date | 2017-08-02 |
| 1y Target Est | N/A |
- Motley Fool•14 hours ago
3 High-Yield Dividend Stocks for Conservative Investors
These rare gems offer both a high yield and an acceptable level of risk.
- Reuters•18 hours ago
SAC Capital's Martoma fails to overturn U.S. insider trading conviction
A divided federal appeals court on Wednesday upheld the insider trading conviction of Mathew Martoma, a former portfolio manager for billionaire Steven A. Cohen's SAC Capital Advisors LP, after the U.S. Supreme Court made such cases easier to pursue. The 2nd U.S. Circuit Court of Appeals in Manhattan found "overwhelming" evidence that a Michigan doctor received financial benefits from providing confidential information to Martoma about a 2008 Alzheimer's drug trial.
- Zacks•22 hours ago
Pfizer's Ibrance in First-Line Combo Breast Cancer Study
Pfizer, Inc. (PFE) and six international cancer research groups are collaborating on a combination study to explore the use of Ibrance for first-line treatment of advanced breast cancer.
